71 – 80 of 217
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Role of histopathology and molecular markers in the active surveillance of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction
(
- Contribution to journal › Article
-
Mark
Particle Therapy - A next logical step in the improvement of radiotherapy
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
(
- Contribution to journal › Article
-
Mark
Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Monte Carlo calculations of absorbed doses in tumours using a modified MOBY mouse phantom for pre-clinical dosimetry studies.
(
- Contribution to journal › Article
-
Mark
Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers.
(
- Contribution to journal › Article
-
Mark
The accuracy of absorbed dose estimates in tumours determined by Quantitative SPECT: A Monte Carlo study.
(
- Contribution to journal › Article
-
Mark
Cancer rehabilitation: A Nordic and European perspective.
(
- Contribution to journal › Article
- 2010
-
Mark
Symptoms, care needs and diagnosis in palliative cancer patients in acute care hospitals: A 5-year follow-up survey
(
- Contribution to journal › Article